Stereotactic re-irradiation well-tolerated treatment option. »
12/08/25

T treatment markedly reduced effective dose of Carboplatin and enhanced apoptosis. »
12/08/25

IMRT with weekly cisplatin yields excellent survival and locoregional control. »
12/08/25

larger-scale research warranted to evaluate efficacy of multidisciplinary prehabilitation. »
12/09/25

In ER-positive BC, A3B protein expression marker for poor disease outcome. »
12/09/25

OS and EFS significantly prolonged in patients with a C mean(1−6) > 768 µmol/L. »
12/10/25

Natural product preparations could be viable therapy option for prostate cancer. »
12/10/25

Intraductal injection accelerates tumour growth. »
12/10/25

EBV as key modulator of BL genomic instability and immune remodeling. »
12/10/25

Melanoma patients who did not respond to immunotherapy exhibited increased cellular senescence. »
12/10/25